| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3976667 | Brachytherapy | 2015 | 7 Pages |
Abstract
125I prostate BT is a highly effective treatment option for low-, intermediate-, and selected high-risk prostate cancers. Side effects were tolerable. An adequate dose may be required to achieve successful biochemical control.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Atsunori Yorozu, Nobuko Kuroiwa, Akane Takahashi, Kazuhito Toya, Shiro Saito, Toru Nishiyama, Yasuto Yagi, Tomoki Tanaka, Yutaka Shiraishi, Toshio Ohashi,